Literature DB >> 24504680

CYP1A1 and CYP2E1 genotypes and risk of esophageal squamous cell carcinoma in a high-incidence region, Kashmir.

Gulzar Ahmad Bhat1, Idrees Ayoub Shah, Muzamil Ashraf Makhdoomi, Beenish Iqbal, Rumaisa Rafiq, Sumaiya Nabi, Akbar Masood, Mohd Maqbool Lone, Nazir Ahmad Dar.   

Abstract

The study analyzed the relationship between genetic polymorphisms of phase I xenobiotic metabolizing enzymes, cytochromes P450 (CYP) 1A1 and CYP2E1 and esophageal squamous cell carcinoma (ESCC) in Kashmir, India. The different genotypes of CYP1A1 and CYP2E1 were analyzed by polymerase chain reaction and restriction fragment length polymorphism in 526 ESCC cases and equal number of matched controls. Conditional logistic regression models were used to assess the association of various genotypes with ESCC, gene-gene, and gene-environment interactions. High risk of ESCC was found in participants who carried CYP1A1 Val/Val genotype (OR=2.87; 95 % CI=1.00-8.44) and the risk increased in such individuals when c1/c1 of CYP2E1 genotype was also present (OR=5.68; 95 % CI=1.09-29.52). Risk due to CYP1A1 Val/Val genotype was further enhanced (OR=8.55; 95 % CI=1.86-42.20) when the analysis was limited to ever smokers. Participants who carried CYP2E1 c1/c2 genotype showed an inverse relation (OR=0.27; 95 % CI=0.17-0.43) with ESCC. The inverse association of CYP2E1 c1/c2 genotype was retained when CYP1A1 Ile/Ile was also present (OR=0.18; 95 % CI=0.09-0.32), as well as when analysis was limited to ever smokers (OR=0.45; 95 % CI=0.23-0.90). Significant interaction was found between CYP1A1 (Val/Val) and CYP2E1 (c1/c1) genotypes (OR=1.30; 95 % CI=1.12-1.51; P=0.001) and between CYP1A1 (Val/Val) and smoking (OR=1.31; 95 % CI=1.01-1.69; P=0.043). The study suggests CYP1A1 Val/Val and CYP2E1 c1/c1 genotypes are significantly associated with ESCC risk.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24504680     DOI: 10.1007/s13277-014-1694-6

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  46 in total

1.  Genetic polymorphisms in cytochrome P450 (CYP) 1A1, CYP1A2, CYP2E1, glutathione S-transferase (GST) M1 and GSTT1 and susceptibility to prostate cancer in the Japanese population.

Authors:  M Murata; M Watanabe; M Yamanaka; Y Kubota; H Ito; M Nagao; T Katoh; T Kamataki; J Kawamura; R Yatani; T Shiraishi
Journal:  Cancer Lett       Date:  2001-04-26       Impact factor: 8.679

2.  High exposure to polycyclic aromatic hydrocarbons may contribute to high risk of esophageal cancer in northeastern Iran.

Authors:  Farin Kamangar; Paul T Strickland; Akram Pourshams; Reza Malekzadeh; Paolo Boffetta; Mark J Roth; Christian C Abnet; Mitra Saadatian-Elahi; Nasser Rakhshani; Paul Brennan; Arash Etemadi; Sanford M Dawsey
Journal:  Anticancer Res       Date:  2005 Jan-Feb       Impact factor: 2.480

3.  Novel functional variants locus in PLCE1 and susceptibility to esophageal squamous cell carcinoma: based on published genome-wide association studies in a central Chinese population.

Authors:  Fujiao Duan; Wei Xie; Lihong Cui; Peng Wang; Chunhua Song; Honghong Qu; Kaijuan Wang; Jianying Zhang; Liping Dai
Journal:  Cancer Epidemiol       Date:  2013-05-17       Impact factor: 2.984

Review 4.  The changing incidence of oesophageal cancer.

Authors:  P I Reed; B J Johnston
Journal:  Endoscopy       Date:  1993-11       Impact factor: 10.093

5.  Strong interaction between the effects of alcohol consumption and smoking on oesophageal squamous cell carcinoma among individuals with ADH1B and/or ALDH2 risk alleles.

Authors:  Fumiaki Tanaka; Ken Yamamoto; Sadao Suzuki; Hiroshi Inoue; Masahiko Tsurumaru; Yoshiaki Kajiyama; Hoichi Kato; Hiroyasu Igaki; Koh Furuta; Hiromasa Fujita; Toshiaki Tanaka; Yoichi Tanaka; Yoshiyuki Kawashima; Shoji Natsugoe; Tetsuro Setoyama; Shinkan Tokudome; Koshi Mimori; Naotsugu Haraguchi; Hideshi Ishii; Masaki Mori
Journal:  Gut       Date:  2010-09-09       Impact factor: 23.059

6.  Cytochrome P450 expression in oesophageal cancer.

Authors:  G I Murray; D Shaw; R J Weaver; J A McKay; S W Ewen; W T Melvin; M D Burke
Journal:  Gut       Date:  1994-05       Impact factor: 23.059

7.  Interaction of methylenetetrahydrofolate reductase C677T, cytochrome P4502E1 polymorphism and environment factors in esophageal cancer in Kazakh population.

Authors:  Jiang-Mei Qin; Lei Yang; Bo Chen; Xiu-Mei Wang; Feng Li; Pei-Hua Liao; Lin He
Journal:  World J Gastroenterol       Date:  2008-12-07       Impact factor: 5.742

8.  Prospective study of risk factors for esophageal and gastric cancers in the Linxian general population trial cohort in China.

Authors:  Gina D Tran; Xiu-Di Sun; Christian C Abnet; Jin-Hu Fan; Sanford M Dawsey; Zhi-Wei Dong; Steven D Mark; You-Lin Qiao; Philip R Taylor
Journal:  Int J Cancer       Date:  2005-01-20       Impact factor: 7.396

9.  Dietary sources of N-nitrosamines in a high-risk area for oesophageal cancer--Kashmir, India.

Authors:  M A Siddiqi; A R Tricker; R Kumar; Z Fazili; R Preussmann
Journal:  IARC Sci Publ       Date:  1991

10.  Hookah smoking, nass chewing, and oesophageal squamous cell carcinoma in Kashmir, India.

Authors:  N A Dar; G A Bhat; I A Shah; B Iqbal; M A Makhdoomi; M A Kakhdoomi; I Nisar; R Rafiq; S T Iqbal; A B Bhat; S Nabi; S A Shah; R Shafi; A Masood; M M Lone; S A Zargar; M S Najar; F Islami; P Boffetta
Journal:  Br J Cancer       Date:  2012-10-02       Impact factor: 7.640

View more
  9 in total

1.  Cytochrome P450 1A1 (CYP1A1) polymorphism and susceptibility to esophageal cancer: an updated meta-analysis of 27 studies.

Authors:  Feng-Feng Gong; Shan-Shan Lu; Cai-Yun Hu; Zhen-Zhong Qian; Fang Feng; Yi-Le Wu; Hui-Yun Yang; Ye-Huan Sun
Journal:  Tumour Biol       Date:  2014-07-22

Review 2.  Informing etiologic research priorities for squamous cell esophageal cancer in Africa: A review of setting-specific exposures to known and putative risk factors.

Authors:  V A McCormack; D Menya; M O Munishi; C Dzamalala; N Gasmelseed; M Leon Roux; M Assefa; O Osano; M Watts; A O Mwasamwaja; B T Mmbaga; G Murphy; C C Abnet; S M Dawsey; J Schüz
Journal:  Int J Cancer       Date:  2016-08-24       Impact factor: 7.396

3.  Family history of cancer and the risk of squamous cell carcinoma of oesophagus: a case-control study in Kashmir, India.

Authors:  G A Bhat; I A Shah; R Rafiq; S Nabi; B Iqbal; M M Lone; F Islami; P Boffetta; N A Dar
Journal:  Br J Cancer       Date:  2015-06-30       Impact factor: 7.640

Review 4.  Gene-gene interactions in gastrointestinal cancer susceptibility.

Authors:  Jineun Kim; Seoyun Yum; Changwon Kang; Suk-Jo Kang
Journal:  Oncotarget       Date:  2016-10-11

5.  Identification of the key transcription factors in esophageal squamous cell carcinoma.

Authors:  Yuefeng Zhang; Yanzhao Xu; Zhenhua Li; Yonggang Zhu; Shiwang Wen; Mingbo Wang; Huilai Lv; Fan Zhang; Ziqiang Tian
Journal:  J Thorac Dis       Date:  2018-01       Impact factor: 2.895

6.  Analysis of the role of rs2031920 and rs3813867 polymorphisms within the cytochrome P450 2E1 gene in the risk of squamous cell carcinoma.

Authors:  Hai Zhang; Haiyan Li; Huanxin Yu
Journal:  Cancer Cell Int       Date:  2018-05-01       Impact factor: 5.722

7.  The Interaction of Smoking with Gene Polymorphisms on Four Digestive Cancers: A Systematic Review and Meta-Analysis.

Authors:  Le Du; Lei Lei; Xiaojuan Zhao; Hongjuan He; Erfei Chen; Jing Dong; Yuan Zeng; Jin Yang
Journal:  J Cancer       Date:  2018-04-06       Impact factor: 4.207

8.  ESCC ATLAS: A population wide compendium of biomarkers for Esophageal Squamous Cell Carcinoma.

Authors:  Asna Tungekar; Sumana Mandarthi; Pooja Rajendra Mandaviya; Veerendra P Gadekar; Ananthajith Tantry; Sowmya Kotian; Jyotshna Reddy; Divya Prabha; Sushma Bhat; Sweta Sahay; Roshan Mascarenhas; Raghavendra Rao Badkillaya; Manoj Kumar Nagasampige; Mohan Yelnadu; Harsh Pawar; Prashantha Hebbar; Manoj Kumar Kashyap
Journal:  Sci Rep       Date:  2018-08-24       Impact factor: 4.379

9.  A novel immune-related gene signature predicts survival in esophageal squamous cell carcinoma.

Authors:  Tao Xu; Tianyang Dai; Peiyuan Zeng; Yunfen Guo; Kaiming He
Journal:  Transl Cancer Res       Date:  2021-05       Impact factor: 1.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.